David Miller to Aged
This is a "connection" page, showing publications David Miller has written about Aged.
Connection Strength
0.527
-
Bellinger C, Pinsky P, Foley K, Case D, Dharod A, Miller D. Lung Cancer Screening Benefits and Harms Stratified by Patient Risk: Information to Improve Patient Decision Aids. Ann Am Thorac Soc. 2019 04; 16(4):512-514.
Score: 0.069
-
Miller DP, Denizard-Thompson N, Weaver KE, Case LD, Troyer JL, Spangler JG, Lawler D, Pignone MP. Effect of a Digital Health Intervention on Receipt of Colorectal Cancer Screening in Vulnerable Patients: A Randomized Controlled Trial. Ann Intern Med. 2018 04 17; 168(8):550-557.
Score: 0.064
-
Pinsky PF, Bellinger CR, Miller DP. False-positive screens and lung cancer risk in the National Lung Screening Trial: Implications for shared decision-making. J Med Screen. 2018 06; 25(2):110-112.
Score: 0.062
-
Duren-Winfield V, Onsomu EO, Case DL, Pignone M, Miller D. Health literacy and computer-assisted instruction: usability and patient preference. J Health Commun. 2015 Apr; 20(4):491-8.
Score: 0.052
-
Miller DP, Watkins SE, Sampson T, Davis KJ. Long-term use of fluticasone propionate/salmeterol fixed-dose combination and incidence of cataracts and glaucoma among chronic obstructive pulmonary disease patients in the UK General Practice Research Database. Int J Chron Obstruct Pulmon Dis. 2011; 6:467-76.
Score: 0.041
-
Miller DP, Spangler JG, Case LD, Goff DC, Singh S, Pignone MP. Effectiveness of a web-based colorectal cancer screening patient decision aid: a randomized controlled trial in a mixed-literacy population. Am J Prev Med. 2011 Jun; 40(6):608-15.
Score: 0.040
-
Miller DP, Kimberly JR, Case LD, Wofford JL. Using a computer to teach patients about fecal occult blood screening. A randomized trial. J Gen Intern Med. 2005 Nov; 20(11):984-8.
Score: 0.027
-
Miller DP, Neuberg D, de Vivo I, Wain JC, Lynch TJ, Su L, Christiani DC. Smoking and the risk of lung cancer: susceptibility with GSTP1 polymorphisms. Epidemiology. 2003 Sep; 14(5):545-51.
Score: 0.024
-
Miller DP, De Vivo I, Neuberg D, Wain JC, Lynch TJ, Su L, Christiani DC. Association between self-reported environmental tobacco smoke exposure and lung cancer: modification by GSTP1 polymorphism. Int J Cancer. 2003 May 10; 104(6):758-63.
Score: 0.023
-
Palakshappa D, Ip EH, Berkowitz SA, Bertoni AG, Foley KL, Miller DP, Vitolins MZ, Rosenthal GE. Pathways by Which Food Insecurity Is Associated With Atherosclerotic Cardiovascular Disease Risk. J Am Heart Assoc. 2021 Nov 16; 10(22):e021901.
Score: 0.021
-
Patel N, Miller DP, Snavely AC, Bellinger C, Foley KL, Case D, McDonald ML, Masmoudi YR, Dharod A. A Comparison of Smoking History in the Electronic Health Record With Self-Report. Am J Prev Med. 2020 04; 58(4):591-595.
Score: 0.018
-
Lewis JA, Petty WJ, Tooze JA, Miller DP, Chiles C, Miller AA, Bellinger C, Weaver KE. Low-Dose CT Lung Cancer Screening Practices and Attitudes among Primary Care Providers at an Academic Medical Center. Cancer Epidemiol Biomarkers Prev. 2015 Apr; 24(4):664-70.
Score: 0.013
-
Koliscak LP, Johnson JW, Beardsley JR, Miller DP, Williamson JC, Luther VP, Ohl CA. Optimizing empiric antibiotic therapy in patients with severe ß-lactam allergy. Antimicrob Agents Chemother. 2013 Dec; 57(12):5918-23.
Score: 0.012
-
Denizard-Thompson NM, Feiereisel KB, Stevens SF, Miller DP, Wofford JL. The digital divide at an urban community health center: implications for quality improvement and health care access. J Community Health. 2011 Jun; 36(3):456-60.
Score: 0.010
-
Zhou W, Heist RS, Liu G, Asomaning K, Miller DP, Neuberg DS, Wain JC, Lynch TJ, Christiani DC. Second hand smoke exposure and survival in early-stage non-small-cell lung cancer patients. Clin Cancer Res. 2006 Dec 01; 12(23):7187-93.
Score: 0.007
-
Zhou W, Park S, Liu G, Miller DP, Wang LI, Pothier L, Wain JC, Lynch TJ, Giovannucci E, Christiani DC. Dietary iron, zinc, and calcium and the risk of lung cancer. Epidemiology. 2005 Nov; 16(6):772-9.
Score: 0.007
-
Thurston SW, Liu G, Miller DP, Christiani DC. Modeling lung cancer risk in case-control studies using a new dose metric of smoking. Cancer Epidemiol Biomarkers Prev. 2005 Oct; 14(10):2296-302.
Score: 0.007
-
Liu G, Zhou W, Wang LI, Park S, Miller DP, Xu LL, Wain JC, Lynch TJ, Su L, Christiani DC. MPO and SOD2 polymorphisms, gender, and the risk of non-small cell lung carcinoma. Cancer Lett. 2004 Oct 08; 214(1):69-79.
Score: 0.006
-
Gong MN, Wei Z, Xu LL, Miller DP, Thompson BT, Christiani DC. Polymorphism in the surfactant protein-B gene, gender, and the risk of direct pulmonary injury and ARDS. Chest. 2004 Jan; 125(1):203-11.
Score: 0.006
-
Zhou W, Liu G, Miller DP, Thurston SW, Xu LL, Wain JC, Lynch TJ, Su L, Christiani DC. Polymorphisms in the DNA repair genes XRCC1 and ERCC2, smoking, and lung cancer risk. Cancer Epidemiol Biomarkers Prev. 2003 Apr; 12(4):359-65.
Score: 0.006
-
Xu LL, Liu G, Miller DP, Zhou W, Lynch TJ, Wain JC, Su L, Christiani DC. Counterpoint: the myeloperoxidase -463G-->a polymorphism does not decrease lung cancer susceptibility in Caucasians. Cancer Epidemiol Biomarkers Prev. 2002 Dec; 11(12):1555-9.
Score: 0.006
-
Zhou W, Liu G, Thurston SW, Xu LL, Miller DP, Wain JC, Lynch TJ, Su L, Christiani DC. Genetic polymorphisms in N-acetyltransferase-2 and microsomal epoxide hydrolase, cumulative cigarette smoking, and lung cancer. Cancer Epidemiol Biomarkers Prev. 2002 Jan; 11(1):15-21.
Score: 0.005